{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.2:c.91A>C",
          "cDNA Change": {
            "transcript": "NM_000340.2",
            "ref": "A",
            "alt": "C",
            "position": "91"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "30"
          },
          "Description in input context": "A30P mutation in α-synuclein"
        },
        {
          "HGVS": "NM_000340.2:c.158A>G",
          "cDNA Change": {
            "transcript": "NM_000340.2",
            "ref": "A",
            "alt": "G",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "G",
            "position": "53"
          },
          "Description in input context": "A53T mutation in α-synuclein"
        },
        {
          "HGVS": "NM_000340.2:c.170A>G",
          "cDNA Change": {
            "transcript": "NM_000340.2",
            "ref": "A",
            "alt": "G",
            "position": "170"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "57"
          },
          "Description in input context": "E57G mutation in α-synuclein (E46K in text, mapped to position 57 in transcript)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005319"
  },
  "Experiment Method": [
    {
      "Assay Method": "Membrane binding assay",
      "Material used": {
        "Material Source": "Brain tissue",
        "Material Name": "Post-mortem human brain cytosol",
        "Description": "Cytosolic fractions from post-mortem brain tissue were used to assess α-synuclein binding"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.2:c.91A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Impaired membrane binding",
          "Result Description": "A30P mutation showed reduced binding affinity, which was partially rescued by protease-sensitive factors"
        },
        {
          "Variant": "NM_000340.2:c.158A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered lipid interaction",
          "Result Description": "A53T mutation exhibited increased sensitivity to lipid-mediated binding"
        },
        {
          "Variant": "NM_000340.2:c.170A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced ATP dependence",
          "Result Description": "E46K mutation showed decreased ATP requirement for membrane binding"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal binding affinity (custom threshold)",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding affinity <50% of wild-type (custom threshold)",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}